Mediscience Planning

Mediscience Planning Inc. (MPI) is a prominent Japanese Contract Research Organization (CRO) and Contract Sales Organization (CSO) established in 1982. The company provides comprehensive clinical development services, including monitoring, data management, biostatistics, and regulatory consulting, with a specialized focus on the Japanese market. As a wholly-owned subsidiary of M3 Inc., MPI integrates advanced digital healthcare platforms and a vast network of physicians to streamline clinical trials and post-marketing surveillance. Through its Integrated Innovation Service Center (IISC), MPI supports global biopharmaceutical companies in navigating Japan's regulatory landscape, offering 'In-Country Clinical Caretaker' (ICCC) services for pharmaceuticals, regenerative medicines, and medical devices. Their expertise spans various therapeutic areas, including oncology, cardiovascular disease, and central nervous system disorders.